<qa>  What is FDA approved for the treatment of multiple myeloma and MDS?This is an investigational study. Lenalidomide is FDA approved for the treatment of multiple myeloma MM and myelodysplastic syndrome MDS. Rituximab is FDA approved for the treatment of non-Hodgkins lymphoma and certain types of leukemia. Carfilzomib is FDA approved and commercially available for the treatment of certain types of MM. The combination of these drugs is investigational. 